drugset / Trial / NCT05314842
Pulpotomy in Primary Molars Treated With Premixed Bio-ceramic MTA Versus Formocresol
RandomizedParallel-groupSingle-blindTreatment
Summary
examine the results of pulpotomy in primary molars using premixed bioceramic MTA versus Formocresol. Clinical and radiographic success rates were used as outcomes.
Timeline
- Start
- 2022-04-01
- Primary completion
- 2023-04-01
- Completion
- 2023-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Formocresol | Other / unclassified | — | — |
| Subject | Premixed bioceramic MTA | Other / unclassified | — | — |